Breakfast replacement by a low-glycemic index liquid formula in patients with diabetes mellitus type 2

• Conditions: diabetes; 10018424

• Registration Number: NL-OMON34073
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

diabetes mellitus type 2

Exclusion Criteria

- use of any other anti-diabetic drug than metformin
- acute or chronic metabolic disease (other than diabetes) that will impair metabolism or digestion and absorption of food, including gastrointestinal, hepatic or renal disease
- regular breakfast skipping
- inability to give written informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Fasting and postprandial glucose and insulin concentrations</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>body weight, HbA1c, glucose tolerance (determined by an oral glucose tolerance<br /><br>test), plasma lipid concentrations, oxidative stress </p><br>